RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Abroad (travel likely)RecruitingPHASE2
Conditions
Focal Onset Seizures
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Medsol Clinical Research Center, Port Charlotte, Florida, United States
Study leads
Maciej Gasior, MD, PhD
Study Director
Supernus Pharmaceuticals, Inc.